Sun Pharma Advanced Research Company Q1 net loss at Rs 2.51 cr

Tags: Companies
Sun Pharma Advanced Research Company today reported a net loss of Rs 2.51 crore for the first quarter ended March 31, 2014, mainly on account of increase in expenses during the period.

The company had posted a net profit of Rs 44.04 crore during the same period of previous fiscal, Sun Pharma Advanced Research Company Ltd (SPARC) said in a statement.

Total income of the company declined to Rs 42.57 crore during the first quarter, as compared to Rs 71.83 crore in the same period of previous fiscal.

The company's expenses during the quarter rose by 78.43 per cent to Rs 48.16 crore in the first quarter, as against Rs 26.99 crore during the same period of previous fiscal.

SPARC was demerged from Sun Pharmaceutical Industries Ltd as a research and drug discovery company in 2007.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • It will take at least 4 more quarters for corporate bottomlines to turn around

    Aggregate numbers from corporate results in the June quarter of 2014-15 are hardly different from the previous six quarters, with no positive surprise

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Tushar Gandhi

Dealing with a sin called insensitivity

Rage and the notion of being above the law — ...

Kuruvilla Pandikattu SJ

India’s greatest gift to the world

What we hear most often about India these days is ...

Gautam Gupta

Why must innerwear be our best kept secret?

While women’s outerwear rules the marketing roost in India, unfortunately, ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture